A role for psychedelics in psychiatry?

R. Sandison

28 The Southend, Ledbury, Herefordshire HR8 2EY, UK

EDITED BY KIRIAKOS XENITIDIS and COLIN CAMPBELL

The editorial by Dr Sessa is both timely and encouraging. The almost complete denial, not only by the media but also by the psychiatric establishment, that lysergic acid diethylamide (LSD) and related psychedelics had an important place in the therapy of a wide range of psychoneurotic disorders is astonishing. This clearly has a psychodynamic explanation.

The interest shown during the 1950s and 1960s by the psychiatric establishment in the use of the psycholytic agents is even greater than Dr Sessa indicates. The meeting of the ‘American Psychological Association’ at which the therapeutic use of LSD was discussed was actually held at the Annual Meeting of the prestigious American Psychiatric Association, in 1955, rather than 1951 (Cholden, 1956). Subsequently, the role of psychedelics in therapy was the subject of a number of national and international conferences. Perhaps the most significant of these was held in London in February 1961, when the Royal Medico-Psychological Association, the forerunner of the Royal College of Psychiatrists, devoted the whole of its 3 day quarterly meeting to the subject (Crocket et al, 1963).

Dr Sessa touches briefly on the question of the possible resumption of psycholytic therapy. There have been a number of recent suggestions that this could once more become a possibility. Psychiatrists tempted to enter this field (assuming that the appropriate drugs – LSD, 3,4-methylenedioxymethamphetamine (MDMA), psilocybin – are made legally available to doctors) should bear in mind that the success of psycholytic therapy depended on careful training, not only of the therapist, but also of the nurses and others who formed the therapeutic team. That expertise at one time reached a high level, and all that has been lost. My hope is that research and practice will continue, and that it will be supported by the College.

REFERENCES

Cholden, L. (ed.) (1956) Proceedings of the Round Table on Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry. New York: Grune & Stratton.

Crocket, R., Sandison, R. A. & Walk, A. (eds) (1963) Hallucinogenic Drugs and their Therapeutic Use. Proceedings of the Quarterly Meeting of the Royal Medico-Psychological Association in London 1961. London: H. K. Lewis.

Sessa, B. (2005) Can psychedelics have a role in psychiatry once again? British Journal of Psychiatry, 186, 457 –458.[Free Full Text]





This Article
Full Text (PDF)
Submit a response
Alert me when this article is cited
Alert me when eLetters are posted
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Sandison, R.
PubMed
PubMed Citation
Articles by Sandison, R.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals